BiotechTube
Home/TIXiMED/T. Michael Goodrich, II, JD
TM

T. Michael Goodrich, II, JD

President, Executive Board Chair, General Counsel

TIXiMED

Therapeutic Areas

Type 1 DiabetesType 2 DiabetesMASLD/MASH

TIXiMED Pipeline

DrugIndicationPhase
TIX100Type 1 Diabetes, Type 2 Diabetes, MASLD/MASHPhase 1

Leadership Team at TIXiMED

AS
Anath Shalev, MD
Founder, Chief Scientific Officer, Chief Medical Officer
SD
Stephen Daly
Chief Executive Officer & Chief Financial Officer
View full TIXiMED profile